Conditions: Major Depressive Disorder
Keywords: MDD
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 437
Healthy volunteers: no

Brief summary:
This study will be conducted with the aim of investigating the efficacy, safety and tolerability of 10 mg/day Vortioxetine in Asian patients compared to an approved active comparator (venlafaxine extended release 150 mg/day).

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Vortioxetine (Lu AA21004) intervention 2: Venlafaxine extended release
Intervention descriptions: intervention 1: 10 mg/day intervention 2: 150 mg/day

Protocol document: